UnitedHealth Group Incorporated (UNH)

NYSE · Health Care · Healthcare Plans
By Alex · Tickerpine
$405.59
+3.40 (+0.85%)
Price — last 10 years monthly, dividend-adjusted · hover for detail
Market Cap
$364.06B
P/E (TTM)
26.0
Forward P/E
18.1
EPS (TTM)
$15.57
ROE
14.15%
Profit Margin
3.14%
Revenue Growth
0.40%
Dividend Yield
2.29%
Beta
0.63
52W High
$461.62
52W Low
$255.97
Analyst Target
$475.23

UNH stock forecast: what analysts expect

Consensus rating
Buy
Avg. 12-month target
$475.23
Implied upside
+17.2%

Wall Street analysts covering UnitedHealth Group Incorporated currently rate the stock a Buy on average, with a mean 12-month price target of $475.23 — +17.2% versus the last price of $405.59. Targets reflect analyst opinion, not a guarantee.

What would an investment in UNH be worth today?
Run UNH through our free historical return calculator.
Calculate UNH returns →

UNH historical returns

PeriodTotal returnAnnualized (CAGR)$1,000 grew to
1 year +34.4% +34.4% $1,344
3 years -9.6% -3.3% $904
5 years +6.4% +1.2% $1,064
10 years +252% +13.4% $3,516
20 years +917% +12.3% $10,172
Since 1985 +272,291% +21.0% $2,723,909

Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in UNH.

UNH annual returns by year

2026 YTD +24.5%
2025 -33.1%
2024 -2.4%
2023 +0.8%
2022 +6.9%
2021 +45.2%
2020 +21.3%
2019 +20.0%
2018 +14.5%
2017 +39.8%

Congress trading in UNH

47 members of Congress have disclosed trading UNH — 60 purchases and 44 sales worth an estimated $2.3M. Most recent disclosure: Jul 10, 2026.

See who in Congress traded UNH →

Insider activity in UNH

UNH's own executives and directors have made 0 open-market purchases ($0) and 1 sale ($205,000) in the last 90 days, per SEC Form 4 filings. Most recent: Aug 5, 2026.

Aug 5, 2026Conway Patrick Hugh Chief Executive Officer, Optum Sell $205,000

About UnitedHealth Group Incorporated

UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.

Company website ↗

UNH Key Statistics

Previous Close$402.19P/E Ratio26.0
Market Cap$364.06BPEG Ratio1.26
Revenue (TTM)$450.13BROE14.15%
Gross Margin19.51%ROA4.38%
Debt / Equity69.2Employees390,000

UNH in plain English

UNH stock: frequently asked questions

What is UnitedHealth Group Incorporated's stock price today?

UnitedHealth Group Incorporated (UNH) last traded at $405.59 on the NYSE. Over the past 52 weeks the stock has traded between $255.97 and $461.62.

Is UNH stock a buy or a sell?

Wall Street analysts' consensus rating on UNH is "Buy", with an average 12-month price target of $475.23 — about +17.2% versus the current price of $405.59. Analyst targets are opinions, not guarantees; always do your own research.

How much would $1,000 invested in UNH 10 years ago be worth today?

A $1,000 investment in UnitedHealth Group Incorporated made 10 years ago would be worth about $3,516 today (dividends reinvested) — a total return of 252%, or 13.4% per year.

Does UNH pay a dividend?

Yes. UnitedHealth Group Incorporated currently pays a dividend yielding about 2.29% per year at today's share price.

What is UNH's P/E ratio?

UNH trades at a trailing price-to-earnings ratio of 26.0, and 18.1 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.

Do members of Congress trade UNH stock?

Yes — 47 members of Congress have disclosed trades in UNH under the STOCK Act, totaling 60 purchases and 44 sales worth an estimated $2.3M.

What is UnitedHealth Group Incorporated's ticker symbol?

UnitedHealth Group Incorporated trades under the ticker symbol UNH on the NYSE.

Compare UNH with peers

UNH vs LLYEli Lilly and Company $1,220.28 UNH vs JNJJohnson & Johnson $260.86 UNH vs ABBVAbbVie Inc. $248.76 UNH vs MRKMerck & Company, Inc. $132.92 UNH vs AMGNAmgen Inc. $416.18

Data last refreshed from public sources. Figures may be delayed. Not investment advice.